Lindsey A Sjaarda1, Sunni L Mumford, Kerri Kissell, Karen C Schliep, Ahmad O Hammoud, Neil J Perkins, Jennifer Weck, Jean Wactawski-Wende, Enrique F Schisterman. 1. Division of Intramural Population Health Research (L.A.S., S.L.M., K.K., K.C.S., N.J.P., J.W., E.F.S.) and Program of Reproductive and Adult Endocrinology (K.K.), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; Division of Reproductive Endocrinology and Infertility (A.O.H.), Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, Utah 84132; and Department of Social and Preventive Medicine (J.W.-W.), School of Public Health and Health Professions, University at Buffalo, Buffalo, New York 14214.
Abstract
CONTEXT: Hyperandrogenism is a hallmark of polycystic ovary syndrome (PCOS) in women with irregular menses, yet the relationship between androgens and ovarian dysfunction remains poorly understood in eumenorrheic women. OBJECTIVE: The objective of the study was to evaluate whether sporadic anovulation was associated with higher T and anti-müllerian hormone (AMH; marker of ovarian follicle count) concentrations in eumenorrheic women. DESIGN: This was a prospective cohort study from 2005 to 2007. SETTING: The study was conducted at the University of Buffalo in western New York state. PARTICIPANTS: A total of 259 eumenorrheic women without a self-reported history of infertility, PCOS, or other endocrine disorder participated in the study. MAIN OUTCOME MEASURES: Total T and AMH were measured five to eight times per cycle for one (n = 9) or two (n = 250) cycles per woman (n = 509 cycles) with timing of menstrual cycle phase assisted by fertility monitors. Anovulatory cycles were defined biochemically by progesterone and LH concentrations. Repeated-measures ANOVA was conducted on log-transformed data with adjustment for age. RESULTS: Compared with ovulatory cycles (n = 467), sporadic anovulatory cycles (n = 42) had marginally higher total and significantly higher free T [mean 23.7 ng/dL (95% confidence interval [CI] 21.4-26.3) vs 21.6 ng/dL (95% CI 20.9-22.3), P = .08, and 0.36 ng/dL (95% CI 0.33-0.40) vs 0.32 ng/dL (95% CI 0.31-0.33), P = .02, respectively] during menses and also throughout the luteal phase (P < .01 for all). Women with higher T had elevated AMH concentrations, increased reporting of a history of acne requiring medical treatment, but not increased hirsutism. CONCLUSIONS: Mechanisms of androgen-related ovulatory dysfunction that characterize PCOS in women with menstrual disturbances may occur across a continuum of T concentrations, including in eumenorrheic women without clinical hyperandrogenism.
CONTEXT: Hyperandrogenism is a hallmark of polycystic ovary syndrome (PCOS) in women with irregular menses, yet the relationship between androgens and ovarian dysfunction remains poorly understood in eumenorrheic women. OBJECTIVE: The objective of the study was to evaluate whether sporadic anovulation was associated with higher T and anti-müllerian hormone (AMH; marker of ovarian follicle count) concentrations in eumenorrheic women. DESIGN: This was a prospective cohort study from 2005 to 2007. SETTING: The study was conducted at the University of Buffalo in western New York state. PARTICIPANTS: A total of 259 eumenorrheic women without a self-reported history of infertility, PCOS, or other endocrine disorder participated in the study. MAIN OUTCOME MEASURES: Total T and AMH were measured five to eight times per cycle for one (n = 9) or two (n = 250) cycles per woman (n = 509 cycles) with timing of menstrual cycle phase assisted by fertility monitors. Anovulatory cycles were defined biochemically by progesterone and LH concentrations. Repeated-measures ANOVA was conducted on log-transformed data with adjustment for age. RESULTS: Compared with ovulatory cycles (n = 467), sporadic anovulatory cycles (n = 42) had marginally higher total and significantly higher free T [mean 23.7 ng/dL (95% confidence interval [CI] 21.4-26.3) vs 21.6 ng/dL (95% CI 20.9-22.3), P = .08, and 0.36 ng/dL (95% CI 0.33-0.40) vs 0.32 ng/dL (95% CI 0.31-0.33), P = .02, respectively] during menses and also throughout the luteal phase (P < .01 for all). Women with higher T had elevated AMH concentrations, increased reporting of a history of acne requiring medical treatment, but not increased hirsutism. CONCLUSIONS: Mechanisms of androgen-related ovulatory dysfunction that characterize PCOS in women with menstrual disturbances may occur across a continuum of T concentrations, including in eumenorrheic women without clinical hyperandrogenism.
Authors: Ethel Codner; Germán Iñiguez; Isabel M Hernández; Patricia Lopez; Hana K Rhumie; Claudio Villarroel; Rodolfo A Rey Journal: Clin Endocrinol (Oxf) Date: 2011-01 Impact factor: 3.478
Authors: Robert A Wild; Enrico Carmina; Evanthia Diamanti-Kandarakis; Anuja Dokras; Hector F Escobar-Morreale; Walter Futterweit; Rogerio Lobo; Robert J Norman; Evelyn Talbott; Daniel A Dumesic Journal: J Clin Endocrinol Metab Date: 2010-04-07 Impact factor: 5.958
Authors: Sunni L Mumford; Enrique F Schisterman; Anna Maria Siega-Riz; Audrey J Gaskins; Anne Z Steiner; Julie L Daniels; Andrew F Olshan; Mary L Hediger; Kathleen Hovey; Jean Wactawski-Wende; Maurizio Trevisan; Michael S Bloom Journal: Hum Reprod Date: 2010-11-28 Impact factor: 6.918
Authors: Penelope P Howards; Enrique F Schisterman; Jean Wactawski-Wende; Jennifer E Reschke; Andrea A Frazer; Kathleen M Hovey Journal: Am J Epidemiol Date: 2008-10-30 Impact factor: 4.897
Authors: Jean Wactawski-Wende; Enrique F Schisterman; Kathleen M Hovey; Penelope P Howards; Richard W Browne; Mary Hediger; Aiyi Liu; Maurizio Trevisan Journal: Paediatr Perinat Epidemiol Date: 2009-03 Impact factor: 3.980
Authors: Ankita Prasad; Sunni L Mumford; Germaine M Buck Louis; Katherine A Ahrens; Lindsey A Sjaarda; Karen C Schliep; Neil J Perkins; Kerri A Kissell; Jean Wactawski-Wende; Enrique F Schisterman Journal: Horm Behav Date: 2014-06-20 Impact factor: 3.587
Authors: Lindsey A Sjaarda; Sunni L Mumford; Daniel L Kuhr; Tiffany L Holland; Robert M Silver; Torie C Plowden; Neil J Perkins; Enrique F Schisterman Journal: Fertil Steril Date: 2018-02-07 Impact factor: 7.329
Authors: D H Abbott; B H Rayome; D A Dumesic; K C Lewis; A K Edwards; K Wallen; M E Wilson; S E Appt; J E Levine Journal: Hum Reprod Date: 2017-04-01 Impact factor: 6.918
Authors: Sunni L Mumford; Richard W Browne; Keewan Kim; Christina Nichols; Brian Wilcox; Robert M Silver; Matthew T Connell; Tiffany L Holland; Daniel L Kuhr; Ukpebo R Omosigho; Neil J Perkins; Rose Radin; Lindsey A Sjaarda; Enrique F Schisterman Journal: J Clin Endocrinol Metab Date: 2018-12-01 Impact factor: 5.958
Authors: Allison A Eubanks; Carrie J Nobles; Micah J Hill; Alan H DeCherney; Keewan Kim; Lindsey A Sjaarda; Neil J Perkins; Aijun Ye; Jessica R Zolton; Robert M Silver; Enrique F Schisterman; Sunni L Mumford Journal: Reprod Toxicol Date: 2020-09-09 Impact factor: 3.143
Authors: Shvetha M Zarek; Emily M Mitchell; Lindsey A Sjaarda; Sunni L Mumford; Robert M Silver; Joseph B Stanford; Noya Galai; Mark V White; Karen C Schliep; Alan H DeCherney; Enrique F Schisterman Journal: J Clin Endocrinol Metab Date: 2015-09-25 Impact factor: 5.958
Authors: Karen C Schliep; Enrique F Schisterman; Jean Wactawski-Wende; Neil J Perkins; Rose G Radin; Shvetha M Zarek; Emily M Mitchell; Lindsey A Sjaarda; Sunni L Mumford Journal: Am J Clin Nutr Date: 2016-05-25 Impact factor: 7.045